植入左心室辅助装置的患者中抑郁症:揭示病理生理机制和对患者护理的影响
Hilmi Alnsasra1,2, Fouad Khalil3, Radha Kanneganti Perue4
1Cardiology Division, Soroka University Medical Center, Beer-Sheva 8410501, Israel.
International journal of molecular sciences
|July 29, 2023
概括
左心室辅助装置 (LVAD) 植入可能会增加心力衰竭患者的抑郁风险. 早期的精神病学评估和持续的心理健康支持对于管理这种风险至关重要.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 医疗器械 医疗器械
背景情况:
- 抑郁症是一种严重的精神疾病,与较高的死亡率有关.
- 左心室辅助器件 (LVADs) 改善了末期心力衰竭的生存率.
- 接受LVAD治疗的人患抑郁症和自杀企图的比率增加.
研究的目的:
- 审查LVAD植入与抑郁症之间的关联.
- 探索LVAD相关抑郁症的潜在病理机制.
- 讨论目前对抑郁的LVAD患者的治疗策略.
主要方法:
- 对现有证据的文献审查.
- 对LVAD植入和心理健康结果的数据分析.
- 综合病理机制和治疗方法.
主要成果:
- 累积的数据表明,在LVAD接受者中,抑郁症的发病率较高.
- 将LVAD与抑郁症联系在一起的病理机制需要进一步研究.
- 目前正在审查抑郁型LVAD患者的治疗策略.
结论:
- 对于LVAD候选人来说,严格的植入前精神病评估是必不可少的.
- 需要在植入后继续进行心理健康评估.
- 对于LVAD患者,应根据需要进行抗抑郁药治疗.
相关概念视频
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Heart Failure III: Clinical Manifestations
23
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
23
Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15


